Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
about
P1343
Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainmentProtection of Cattle against Rinderpest by Vaccination with Wild-Type but Not Attenuated Strains of Peste des Petits Ruminants Virus.Characterization of Vesicular Stomatitis Virus Pseudotypes Bearing Essential Entry Glycoproteins gB, gD, gH, and gL of Herpes Simplex Virus 1.Cotton rat (Sigmodon hispidus) signaling lymphocyte activation molecule (CD150) is an entry receptor for measles virusExtracellular vesicles: a platform for the structure determination of membrane proteins by Cryo-EM.Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Use of replication restricted recombinant vesicular stomatitis virus vectors for detection of antigen-specific T cellsDevelopment and Applications of VSV Vectors Based on Cell TropismDigital sensing and sizing of vesicular stomatitis virus pseudotypes in complex media: a model for Ebola and Marburg detectionEfficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies.Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypesRetargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell LeukemiaAnterograde or Retrograde Transsynaptic Circuit Tracing in Vertebrates with Vesicular Stomatitis Virus VectorsVesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytesAntibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteCharacterization of the Bas-Congo virus glycoprotein and its function in pseudotyped virusesSingle injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection.Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expressionMutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.Vaccine platforms to control Lassa fever.Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles.Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.Generating Recombinant Vesicular Stomatitis Viruses for Use as Vaccine Platforms.Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomainsHighly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activityThe Establishment of an Antiviral State by Pyrimidine Synthesis Inhibitor is Cell Type-Specific.Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses.Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding.Current status on the development of pseudoviruses for enveloped viruses.Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug LibraryTechnical considerations for the generation of novel pseudotyped viruses
P2860
Q28731583-9F63B20C-8A1F-49A4-AE0D-9A6A974410A8Q30152165-2A6CA128-A1FD-4CF2-867E-F23FD03DB284Q30353044-3CAC3EFA-E244-40F3-B66D-77B867EEDEDFQ34308888-7431DF7A-4714-4575-BBAB-83816B349540Q34496990-ED01384C-A774-4E0A-9E78-8092E85F280BQ35077419-FB4D1D80-67C9-483A-B856-3ABD83FAB789Q35399141-714CC1F5-CD9B-4B29-8FD8-20158F9F9035Q35661339-A677ABCE-EFAA-4AF3-BFE8-0735F481344EQ35679152-B778DA5D-7F1B-4BAB-943A-DC2B1C2E8A98Q35738767-EF1BC8D3-A21E-447D-B438-4DE3CC6F1C2EQ35878839-92E19EDD-8145-4284-BECB-2F2A81D7414DQ36164148-50A76D68-3B82-4859-8D67-E387F40F280AQ36281149-96B0EBB4-2396-4E68-B0BD-59AC1292E2C8Q36645926-E267DA2D-4F0E-4331-836D-21F60536D0E4Q36911654-908307B4-E8A2-4000-81B9-54B787CC69FDQ36913606-44291CD3-58B3-4A22-B85E-20239FAC7241Q37123432-ADD44D56-39C9-4A38-8E25-6C51D5F3D46EQ37427047-53749663-FA4C-44BE-9083-7C42A5B2DDB3Q37707466-8536C310-F27A-4DA4-8CCC-B53DDDDFCFD6Q37713959-ECA2C014-F076-4519-96A5-85972E3F753BQ38286161-6661BD79-9CF1-4DA3-A310-67C5FEF9977AQ38662402-2C58C7AC-614E-45C4-971E-A384502D0C8CQ38823264-DE282B33-F769-4112-B718-6EA98F01C037Q38880125-030C8E79-FAC0-4A41-B0BF-D96F421005DFQ38956481-E42BE195-8F39-4EFC-BED1-BFED4CE1EE8CQ40039979-4AB37D47-B973-4E64-BDF1-10D924E50E01Q40101206-F5777FCE-18B8-430A-BCDC-618203BB69CAQ40109981-28C46071-98FF-4914-97EA-5BE21082F0F7Q40259589-4FCB332B-7EA7-4041-A718-8D4B00BC374EQ41014846-5F270B20-C311-41D9-AA16-F2A2D3F90F75Q41770092-59EB0064-69B7-454E-A5B6-D2E04FE34279Q42428805-EA77A47F-5E42-4A84-89B8-85DF002C7C49Q46237369-9AD90D4C-14F0-4137-82BA-37A4AD788884Q47242905-C632ADBF-CD32-4285-B053-C61B1269B61BQ47568014-99676ACA-D966-461D-90A9-63CA69C3B72DQ56999457-B426AE06-7DA5-4A2B-AD3E-9FE8D1E8B60AQ57275154-38EA5CEA-1D77-416D-99E3-C56C1969F566
P2860
Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Generation of VSV pseudotypes ...... d immune responses to vaccines
@ast
Generation of VSV pseudotypes ...... d immune responses to vaccines
@en
type
label
Generation of VSV pseudotypes ...... d immune responses to vaccines
@ast
Generation of VSV pseudotypes ...... d immune responses to vaccines
@en
prefLabel
Generation of VSV pseudotypes ...... d immune responses to vaccines
@ast
Generation of VSV pseudotypes ...... d immune responses to vaccines
@en
P2860
P1476
Generation of VSV pseudotypes ...... d immune responses to vaccines
@en
P2093
Michael A Whitt
P2860
P304
P356
10.1016/J.JVIROMET.2010.08.006
P4510
P577
2010-08-13T00:00:00Z